Evonik Acquires 3D Printing Start-Up Structured Polymers to Expand in AM Market

Evonik has acquired Structured Polymers Inc., a US-based technology startup for 3D printing materials headquartered in Austin, Texas. A corresponding agreement and plan of merger was executed and the transaction has been closed recently.

The acquisition will provide Evonik access to a new patented technology that will allow the company to expand its portfolio of specialty polymer powders in the additive manufacturing market.

Expanding 3D Printing Polymers Portfolio

“The acquisition of Structured Polymers’ technology excellently complements our existing activities with high-performance polymers for additive manufacturing,” says Dr. Ralph Marquardt, the head of Strategy and Growth Businesses for Evonik Resource Efficiency GmbH. “Thanks to our decades of expertise in polymer chemistry, this means we will expand our portfolio of customized, ready-to-use polymer materials for the highly attractive, rapidly growing 3D printing market, thus giving us a key role in shaping development of that market.”

Structured Polymers will be entirely integrated into Evonik’s North American organization, while its company headquarters will remain in Austin, Texas.

“We are very pleased to harness the power of Evonik to expand our innovative technology platform even further. In the near future, this will allow us to diversify the 3D printing materials market to a significant degree and to work with our customers on developing new business opportunities,” says Vikram Devarajan, CEO of Structured Polymers Inc.

Evonik already laid the foundations for an acquisition of the technology startup in the fall of 2017 through a venture capital investment.

New Technology for 3D Printing Materials

Structured Polymers’ innovative technology starts with a polymer granulate, which is converted to a fine powder through various process steps.

This makes it possible to produce polymer powders with controlled particle sizes ranging in diameter between 0.1 and 400 µm, while achieving excellent material properties.

Thomas Grosse-Puppendahl, the head of the Additive Manufacturing Innovation Growth Field at Evonik said: “The new technology allows us to take virtually any semi-crystalline thermoplastic, such as polybutylene terephthalate, polyether ketone, or polyamide 6, or polymer powders with specialized properties like color, conductivity, or flame protection, and produce them for common powder-based 3D printing processes, such as selective laser sintering, high-speed sintering, or multi-jet fusion. In addition, we anticipate that Structured Polymers’ technology can be scaled up easily and economically.”

The 3D printing market is booming with double-digit growth rates. Within this market, Evonik is the world’s leading manufacturer of polyamide (PA) 12 powders, which have been used in additive production technologies for over 20 years. In addition to its PEEK filament and PA 12 powders, the company’s product portfolio also includes flexible PEBA powders and a wide array of additives such as dispersing agents, flow enhancers, and reactive modifiers.

Source: https://www.evonik.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evonik Industries AG. (2019, January 23). Evonik Acquires 3D Printing Start-Up Structured Polymers to Expand in AM Market. AZoM. Retrieved on April 16, 2024 from https://www.azom.com/news.aspx?newsID=50280.

  • MLA

    Evonik Industries AG. "Evonik Acquires 3D Printing Start-Up Structured Polymers to Expand in AM Market". AZoM. 16 April 2024. <https://www.azom.com/news.aspx?newsID=50280>.

  • Chicago

    Evonik Industries AG. "Evonik Acquires 3D Printing Start-Up Structured Polymers to Expand in AM Market". AZoM. https://www.azom.com/news.aspx?newsID=50280. (accessed April 16, 2024).

  • Harvard

    Evonik Industries AG. 2019. Evonik Acquires 3D Printing Start-Up Structured Polymers to Expand in AM Market. AZoM, viewed 16 April 2024, https://www.azom.com/news.aspx?newsID=50280.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.